Abstract:Background— We previously demonstrated that macrophage low-density lipoprotein receptor (LDLR)–related protein 1 (LRP1) deficiency increases atherosclerosis despite antiatherogenic changes including decreased uptake of remnants and increased secretion of apolipoprotein E (apoE). Thus, our objective was to determine whether the atheroprotective effects of LRP1 require interaction with apoE, one of its ligands with multiple beneficial effects. Methods and Results— We examined atherosclerosis development in mice with specific deletion of macrophage LRP1 (apoE −/− MΦLRP1 −/− ) and in LDLR −/− mice reconstituted with apoE −/− MΦLRP1 −/− bone marrow. The combined absence of apoE and LRP1 promoted atherogenesis more than did macrophage apoE deletion alone in both apoE-producing LDLR −/− mice (+88%) and apoE −/− mice (+163%). The lesions of both mouse models with apoE −/− LRP1 −/− macrophages had increased macrophage content. In vitro, apoE and LRP1 additively inhibit macrophage apoptosis. Furthermore, there was excessive accumulation of apoptotic cells in lesions of both LDLR −/− mice (+110%) and apoE −/− MΦLRP1 −/− mice (+252%). The apoptotic cell accumulation was partially due to decreased efferocytosis as the ratio of free to cell-associated apoptotic nuclei was 3.5-fold higher in lesions of apoE −/− MΦLRP1 −/− versus apoE −/− mice. Lesion necrosis was also increased (6 fold) in apoE −/− MΦLRP1 −/− versus apoE −/− mice. Compared with apoE −/− mice, the spleens of apoE −/− MΦLRP1 −/− mice contained 1.6- and 2.4-fold more total and Ly6-C high monocytes. Finally, there were 3.6- and 2.4-fold increases in Ly6-C high and CC-chemokine receptor 2–positive cells in lesions of apoE −/− MΦLRP1 −/− versus apoE −/− mice, suggesting that accumulation of apoptotic cells enhances lesion development and macrophage content by promoting the recruitment of inflammatory monocytes. Conclusion— Low-density lipoprotein receptor protein 1 exerts antiatherogenic effects via pathways independent of apoE involving macrophage apoptosis and monocyte recruitment.

Critical Role of Macrophage 12/15-Lipoxygenase for Atherosclerosis in Apolipoprotein E–Deficient Mice

Lox-1 Deletion and Macrophage Trafficking in Atherosclerosis

Macrophage KLF15 prevents foam cell formation and atherosclerosis via transcriptional suppression of OLR-1

Deficiency of LMP10 Attenuates Diet-Induced Atherosclerosis by Inhibiting Macrophage Polarization and Inflammation in Apolipoprotein E Deficient Mice

Deficiency in Lymphotoxin β Receptor Protects From Atherosclerosis in apoE-Deficient Mice

Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages

Myeloid Deletion of α1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice

Augmented Atherogenesis in LDL Receptor Deficient Mice Lacking Both Macrophage ABCA1 and ApoE.

Macrophage-restricted Tyrosine Phosphatase SHP2 is a Novel Anti-Atherosclerotic Regulator

Low-Density Lipoprotein Receptor–Related Protein 1 Prevents Early Atherosclerosis by Limiting Lesional Apoptosis and Inflammatory Ly-6C <sup>high</sup> Monocytosis

Macrophage Paired Immunoglobulin-Like Receptor B Deficiency Promotes Peripheral Atherosclerosis in Apolipoprotein E–Deficient Mice

Abstract 2067: Myeloid Cell Lgr4 Contributes to Atherosclerotic Lesion Formation

Enhanced Foam Cell Formation, Atherosclerotic Lesion Development, and Inflammation by Combined Deletion of ABCA1 and SR-BI in Bone Marrow-Derived Cells in LDL Receptor Knockout Mice on Western-Type Diet.

Low-Density Lipoprotein Receptor-Related Protein 1 Prevents Early Atherosclerosis By Limiting Lesional Apoptosis And Inflammatory Ly-6c(High) Monocytosis Evidence That The Effects Are Not Apolipoprotein E Dependent

Abstract 1339: LOX-1 Ablation Reduces Atherosclerosis

Abstract: P1122 EFFECTS OF MACROPHAGE ABCA7 DEFICIENCY ON LIPID METABOLISM AND THE DEVELOPMENT OF ATHEROSCLEROSIS IN LDL RECEPTOR KNOCKOUT MICE

Hyperlipidemia Induces Typical Atherosclerosis Development in Ldlr and Apoe Deficient Rats.

A Novel Function for 15-Lipoxygenases in Cholesterol Homeostasis and CCL17 Production in Human Macrophages

Protein Tyrosine Phosphatase SHP2 in Macrophages Acts as an Antiatherosclerotic Regulator in Mice

Hematopoietic Cell-Specific SLC37A2 Deficiency Accelerates Atherosclerosis in LDL Receptor-Deficient Mice

Macrophage ABCA5 Deficiency Influences Cellular Cholesterol Efflux and Increases Susceptibility to Atherosclerosis in Female LDLr Knockout Mice.